124 related articles for article (PubMed ID: 11805572)
1. Ectopic production of prolactin by colorectal adenocarcinoma.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
Dis Colon Rectum; 2001 Jan; 44(1):119-27. PubMed ID: 11805572
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of carcinoembryonic antigen messenger ribonucleic acid expression in tumor-draining vein blood on postoperative liver metastasis in patients with colorectal carcinoma: a prospective, cohort study.
Sunouchi K; Machinami R; Mori M; Namiki K; Hattori S; Murata Y; Tsuchiya T; Mizuno H; Tadokoro M
Dis Colon Rectum; 2003 Apr; 46(4):467-73. PubMed ID: 12682539
[TBL] [Abstract][Full Text] [Related]
3. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Vora HH; Shah NG; Chikhlikar PR; Ghosh N
Head Neck; 2000 May; 22(3):257-64. PubMed ID: 10748449
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay.
Schiedeck TH; Wellm C; Roblick UJ; Broll R; Bruch HP
Dis Colon Rectum; 2003 Jun; 46(6):818-25. PubMed ID: 12794585
[TBL] [Abstract][Full Text] [Related]
5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
[TBL] [Abstract][Full Text] [Related]
7. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
[TBL] [Abstract][Full Text] [Related]
9. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.
Yamashita J; Matsuo A; Kurusu Y; Saishoji T; Hayashi N; Ogawa M
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):299-305. PubMed ID: 12167790
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
11. Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator.
Patel DD; Bhatavdekar JM; Ghosh N; Vora HH; Karelia NH; Shah NG; Suthar TP; Balar DB; Trivedi CR
Cancer; 1994 Feb; 73(3):570-4. PubMed ID: 8299078
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen mRNA in the mesenteric vein is not a predictor of hepatic metastasis in patients with resectable colorectal cancer: a long-term study.
Akashi A; Komuta K; Haraguchi M; Ueda T; Okudaira S; Furui J; Kanematsu T
Dis Colon Rectum; 2003 Dec; 46(12):1653-8. PubMed ID: 14668591
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma.
Taniguchi T; Makino M; Suzuki K; Kaibara N
Cancer; 2000 Sep; 89(5):970-6. PubMed ID: 10964326
[TBL] [Abstract][Full Text] [Related]
15. Prolactin and colorectal cancer: is there a connection?
Baert D; Matthys C; Gillardin JP; Lepoutre L; Thienpont L; Kaufman JM; Cuvelier C; De Vos M
Acta Gastroenterol Belg; 1998; 61(4):407-9. PubMed ID: 9923090
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
17. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1.
Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
Dis Colon Rectum; 2007 Nov; 50(11):1887-98. PubMed ID: 17882488
[TBL] [Abstract][Full Text] [Related]
18. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
19. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction.
Sadahiro S; Suzuki T; Tokunaga N; Yurimoto S; Yasuda S; Tajima T; Makuuchi H; Murayama C; Matsuda K
Cancer; 2001 Sep; 92(5):1251-8. PubMed ID: 11571740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
